6th Microbiome Movement – Drug Development Europe 2022

  • January 25, 2022 - January 27, 2022
  • Virtual Conference

Join us:

Biomica is delighted to participate at the 6th Microbiome Movement – Drug Development Europe 2022, January 25-27, 2022 (Virtual Conference).

Dr. Shiri Meshner, VP R&D of Biomica, will be presenting: :From Functional Microbiome LBP Discovery to Clinical Proof of Concept”, January 26th  8:50 am.

For more Details and Registration:
https://microbiome-europe.com/whats-on/day-one/

Back to all News

Highlighted News About Biomica

ASCO 2024 logo
Apr 16, 2024

American Society of Clinical Oncology (ASCO) 2024 Annual Meeting

We’re pleased to announce that Dr. Shiri Meshner, our VP of Research and Development, will be participating in the Pharmabiotic Conference 2024. She’ll be presenting alongside Claire Derlot, Chief Business Officer of Biose Industrie, on the topic “Biomica & Biose Industrie: The clinical journey of a multi-strain LBP”. Additionally, Dr. Meshner will contribute to a panel discussion focusing on Clinical Design & Methodology.